These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8391434)
1. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434 [TBL] [Abstract][Full Text] [Related]
2. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Zhang YJ; Chen CJ; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M; Santella R Carcinogenesis; 1991 Dec; 12(12):2247-52. PubMed ID: 1721008 [TBL] [Abstract][Full Text] [Related]
3. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Chen CJ; Zhang YJ; Lu SN; Santella RM Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290 [TBL] [Abstract][Full Text] [Related]
4. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males. Yu MW; Chiang YC; Lien JP; Chen CJ Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602 [TBL] [Abstract][Full Text] [Related]
5. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015 [TBL] [Abstract][Full Text] [Related]
6. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Yu MW; Lien JP; Liaw YF; Chen CJ Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363 [TBL] [Abstract][Full Text] [Related]
7. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313 [TBL] [Abstract][Full Text] [Related]
8. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Chen SY; Wang LY; Lunn RM; Tsai WY; Lee PH; Lee CS; Ahsan H; Zhang YJ; Chen CJ; Santella RM Int J Cancer; 2002 May; 99(1):14-21. PubMed ID: 11948486 [TBL] [Abstract][Full Text] [Related]
9. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma]. Li J; Tang ZY; Liu KD; Schroder CH Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Wang WL; London WT; Feitelson MA Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208 [TBL] [Abstract][Full Text] [Related]
12. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Hsieh LL; Hsieh TT Cancer Res; 1993 Mar; 53(6):1278-80. PubMed ID: 8383006 [TBL] [Abstract][Full Text] [Related]
13. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702 [TBL] [Abstract][Full Text] [Related]
14. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059 [TBL] [Abstract][Full Text] [Related]
15. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Hsieh LL; Hsu SW; Chen DS; Santella RM Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043 [TBL] [Abstract][Full Text] [Related]
16. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607 [TBL] [Abstract][Full Text] [Related]
17. [Detection of HBxAg in liver specimens of patients with hepatocellular carcinoma]. Jin L Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):288-90. PubMed ID: 1964403 [TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516 [TBL] [Abstract][Full Text] [Related]
19. Determination of aflatoxin B1-DNA adduct in rat liver by enzyme immunoassay. Vidyasagar T; Sujatha N; Sashidhar RB Analyst; 1997 Jun; 122(6):609-13. PubMed ID: 9282405 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish. Lu JW; Yang WY; Lin YM; Jin SL; Yuh CH Acta Histochem; 2013 Sep; 115(7):728-39. PubMed ID: 23499292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]